UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012425
Receipt number R000014530
Scientific Title Efficacy validation study of the psychosocial support program for adult attention deficit / hyperactivity disorder (ADHD)
Date of disclosure of the study information 2013/12/01
Last modified on 2013/11/28 09:10:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy validation study of the psychosocial support program for adult attention deficit / hyperactivity disorder (ADHD)

Acronym

Validation of psychosocial support program for adult ADHD

Scientific Title

Efficacy validation study of the psychosocial support program for adult attention deficit / hyperactivity disorder (ADHD)

Scientific Title:Acronym

Validation of psychosocial support program for adult ADHD

Region

Japan


Condition

Condition

Attention Deficit / Hyperactivity Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To development and to validate the psychosocial support program for adult attention deficit / hyperactivity disorder (ADHD). Core symptoms of ADHD, executive function, anxiety, depression, personality, empathy, tendency of autistic, living conditions and QOL will be compered between before and after program intervention.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The following psychological test will be performed both before and after program.
CPT(Continuous Performance Test)
stroop test
Wisconsin Card Sorting Test
CAARS(Conners' Adult ADHD Rating Scale
STAI(State-Trait Anxiety Inventory)
PHQ-9(Patient Health Questionnaire)

Key secondary outcomes

Before program only (for assessment of participants)
IRI-J(Interpersonal Reactivity Index)
EPQ(Eysenk Personality Questionnaire)
SPQ(Schizotypal Personality Questionnaire)
SFS-J(Social Functioning Scale)
WHO QOL26


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

psychosocial support program

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Adult outpatients at Showa University Karasuyama hospital
2. Patients who diagnosed as ADHD
3. Mentally stable judged by the investigator
4. Patients who understand the content of the study

Key exclusion criteria

Patients who are unsuitable for participation judged by investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Iwanami

Organization

Showa University

Division name

School of Medicine, Department of Psychiatry

Zip code


Address

6-11-11, Kitakarasuyama, Setagaya-ku, Tokyo 157-8577

TEL

03-3300-5231

Email

iwanami@med.showa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Miki Igarashi

Organization

Showa University

Division name

School of Medicine, Department of Psychiatry

Zip code


Address

6-11-11, Kitakarasuyama, Setagaya-ku, Tokyo 157-8577

TEL

03-3300-5231

Homepage URL


Email

m-igarashi@cmed.showa-u.ac.jp


Sponsor or person

Institute

Department of Psychiatry Showa University, School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Meiji Yasuda Mental Health Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学附属烏山病院 発達障害医療研究センター


Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2013 Year 11 Month 29 Day

Date of IRB


Anticipated trial start date

2013 Year 12 Month 16 Day

Last follow-up date

2014 Year 06 Month 01 Day

Date of closure to data entry

2014 Year 08 Month 01 Day

Date trial data considered complete

2014 Year 10 Month 01 Day

Date analysis concluded

2014 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2013 Year 11 Month 28 Day

Last modified on

2013 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014530


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name